YFY Biotech Management Company - Unicorn Nest

YFY Biotech Management Company

YFY Biotech Management Company

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Taiwan, Taipei

About

YFY Biotech Management Company is the renowned VC, which was created in 2003. This investor is located in Asia, Taiwan. The the headquarters of this VC is in Taipei.

Moreover, a start-up needs to be 6-10 years old to get investment from this fund. Among the most popular investment industries for the fund are Test and Measurement, Medical. However, the fund’s focus is not limited to this, since there are 6 more areas of investment. TaiGen Biotechnology, Elixir Pharmaceuticals, Nereus Pharmaceuticals are amongst the various portfolio companies of this fund. The fund has no a preferred number of founders for start-ups that it invests in. When a start-up has 2 or 5+ founders, the probability of closing the deal is low. The country of its establishment and the country of its most frequent investments coincides - Taiwan. However, start-ups from 1 other country can be found in the fund's portfolio.

The most exits for the fund occurred in 2007. YFY Biotech Management Company participates, on average, in 12 percentage points less than the average amount of lead investments in other funds. The fund generally invests in less than 2 deals every year. The most common rounds for this fund are in the range of 10 - 50 millions dollars. The fund's activity peaked in 2006.

Besides the listed founders, we have found 1 key employee of this fund in our database.

The usual method for the fund is to invest in rounds with 5-6 other investors. Aside from YFY Biotech Management Company, start-ups are often funded by China Development Industrial Bank (CDIB), Pacific Venture Group, Novartis Venture Fund and 3 other funds. The most common co-investors for the fund are Taiwan Development Fund, MPM Capital, YFY Inc.. In subsequent rounds, the fund is usually joined by Taiwan Development Fund, Roche Venture Fund, Physic Ventures.

Year Founded

2003

Fund Activity

Not operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

<1

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

14.3% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x9

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

8.1 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.33 out of 1

Funds Investing Together

Taiwan Development Fund, MPM Capital, YFY Inc.

Funds Investing in Following
Rounds

Taiwan Development Fund, Roche Venture Fund, Physic Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: